Altered TNF signaling pathways promote hyperglycemia, hyperlipidemia, and low-grade chronic inflammation, increasing the risk of developing non-communicable metabolic diseases such as type 2 diabetes, non-alcoholic fatty liver disease, cardiovascular disease, chronic kidney disease, and airway disease [42]. Here, TNF is linked to hyperlipidemia.